Twin Tree Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.05M Sell
286,800
-1,097,300
-79% -$29.2M 0.17% 118
2025
Q4
$34.5M Buy
+1,384,100
New +$34.9M 0.3% 53
2025
Q3
Sell
-1,736,800
Closed -$42.1M 1763
2025
Q2
$42.1M Buy
1,736,800
+300
+0% +$7K 0.08% 254
2025
Q1
$44M Sell
1,736,500
-1,501,900
-46% -$39.3M 0.08% 202
2024
Q4
$85.9M Sell
3,238,400
-204,600
-6% -$5.55M 0.15% 114
2024
Q3
$99.6M Buy
3,443,000
+968,500
+39% +$28.3M 0.2% 74
2024
Q2
$69.2M Buy
+2,474,500
New +$68.1M 0.16% 120
2023
Q2
Sell
-82,600
Closed -$3.37M 1460
2023
Q1
$3.37M Sell
82,600
-1,283,600
-94% -$55.4M 0.01% 813
2022
Q4
$70M Sell
1,366,200
-102,200
-7% -$4.9M 0.15% 122
2022
Q3
$64.3M Sell
1,468,400
-890,700
-38% -$43.3M 0.12% 129
2022
Q2
$124M Sell
2,359,100
-318,000
-12% -$16.2M 0.2% 54
2022
Q1
$139M Buy
2,677,100
+2,074,200
+344% +$108M 0.22% 47
2021
Q4
$35.6M Sell
602,900
-1,372,200
-69% -$68M 0.07% 248
2021
Q3
$84.9M Sell
1,975,100
-1,717,600
-47% -$76.1M 0.19% 88
2021
Q2
$145M Buy
3,692,700
+435,500
+13% +$16.9M 0.39% 35
2021
Q1
$118M Buy
3,257,200
+2,306,900
+243% +$81.9M 0.44% 37
2020
Q4
$35M Buy
950,300
+24,256
+3% +$890K 0.14% 155
2020
Q3
$32.2M Buy
926,044
+3,267
+0.4% +$115K 0.13% 164
2020
Q2
$28.6M Buy
+922,777
New +$31.3M 0.12% 200
2020
Q1
Sell
-435,934
Closed -$16.2M 1568
2019
Q4
$16.2M Hold
435,934
0.06% 257
2019
Q3
$14.9M Buy
435,934
+93,700
+27% +$3.41M 0.06% 233
2019
Q2
$14.1M Buy
342,234
+35,731
+12% +$1.42M 0.07% 241
2019
Q1
$12.3M Buy
306,503
+234,936
+328% +$9.41M 0.06% 250
2018
Q4
$2.96M Sell
71,567
-93,700
-57% -$3.89M 0.02% 627
2018
Q3
$6.91M Buy
165,267
+86,322
+109% +$3.32M 0.05% 324
2018
Q2
$2.72M Buy
78,945
+28,775
+57% +$983K 0.02% 563
2018
Q1
$1.69M Buy
+50,170
New +$1.72M 0.01% 557
2017
Q3
Sell
-1,889,295
Closed -$60.2M 1121
2017
Q2
$60.2M Sell
1,889,295
-921,301
-33% -$29.1M 0.47% 29
2017
Q1
$91.2M Buy
2,810,596
+1,116,186
+66% +$35.2M 0.83% 19
2016
Q4
$52.2M Buy
1,694,410
+1,374,099
+429% +$41.9M 0.51% 26
2016
Q3
$10.3M Sell
320,311
-606,893
-65% -$20.3M 0.13% 160
2016
Q2
$31M Buy
+927,204
New +$29.6M 0.49% 28
2015
Q4
Sell
-75,256
Closed -$2.24M 1534
2015
Q3
$2.24M Sell
75,256
-426,553
-85% -$13.7M 0.06% 321
2015
Q2
$16M Sell
501,809
-676,774
-57% -$22.1M 0.39% 39
2015
Q1
$38.9M Buy
1,178,583
+771,739
+190% +$24.5M 0.99% 5
2014
Q4
$12M Buy
406,844
+116,572
+40% +$3.34M 0.34% 46
2014
Q3
$8.14M Sell
290,272
-483,153
-62% -$13.6M 0.22% 79
2014
Q2
$21.8M Buy
773,425
+602,888
+354% +$17.2M 0.49% 17
2014
Q1
$5.2M Buy
170,537
+49,116
+40% +$1.46M 0.11% 220
2013
Q4
$3.53M Buy
121,421
+118,786
+4,508% +$3.46M 0.08% 261
2013
Q3
$72K Sell
2,635
-35,520
-93% -$966K ﹤0.01% 753
2013
Q2
$1.01M Buy
+38,155
New +$1.05M 0.04% 468

Other funds holding PFE

Twin Tree Management's PFE Position: Q4 2025 in Review

Twin Tree Management sold out of Pfizer (PFE) in Q4 2025, closing a stake of 291,400 shares — an estimated $7.35M sold.

Twin Tree Management first reported a position in PFE in Q2 2013 and held it in 25 quarters. The position peaked at $45.4M in Q4 2021. 2,905 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Twin Tree Management reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • Twin Tree Management sold 291,400 Pfizer shares in Q4 2025, an estimated $7.35M.
  • Twin Tree Management first reported a position in Pfizer in Q2 2013 and held it in 25 quarters.
  • Twin Tree Management's Pfizer position peaked at $45.4M in Q4 2021.
  • 2,905 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Twin Tree Management's 13F filing for Q4 2025, filed 11 Feb 2026.